Poor drug delivery to the posterior segment in patients’ eyes is a major obstacle to the treatment of ocular diseases due to its physiological and chemical barriers for transport of large molecular weight molecules such as proteins. In the past few decades, considerable research has been directed towards using lipid based vesicles such as liposomes as drug delivery carriers and results have been promising. In this report, liposomes will be studied as a drug delivery carrier for loading and release of a protein molecule, Ranibizumab (Lucentis) which is approved for the treatment of age related macular degeneration in clinics. Physical Characterization of Lucentis was carried out with the effect of incubation of Lucentis under temperature and...
Several efforts have been focused on targeted drug delivery systems for delivering a drug to a parti...
Liposome drug delivery systems are now being developed for a variety of drugs. Scale-up of processes...
Forty years of liposome research have demonstrated that the anti-tumor efficacy of liposomal therapi...
Poor drug delivery to the posterior segment in patients’ eyes is a major obstacle to the treatment o...
One of the leading causes for blindness in the developed world is Age-related macular degeneration (...
One of the leading causes for blindness in the developed world is Age-related macular degeneration (...
Liposomes can potentially serve as carrier systems for controlled delivery of drugs. The main goal o...
Dry eye disease (DED) is a multifactorial condition resulting in discomfort, visual impairment and e...
In the past thirty years or so, considerable research has been directed towards utilizing lipid bas...
In the past thirty years or so, considerable research has been directed towards utilizing lipid bas...
For treatment of several disorders of the retinal area, the drug molecules need to be directly deliv...
For treatment of several disorders of the retinal area, the drug molecules need to be directly deliv...
MLN-4924 is a newly discovered potent compound that works on the ubiquitin pathway and is currently ...
Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were fi rstdescri...
MLN-4924 is a newly discovered potent compound that works on the ubiquitin pathway and is currently ...
Several efforts have been focused on targeted drug delivery systems for delivering a drug to a parti...
Liposome drug delivery systems are now being developed for a variety of drugs. Scale-up of processes...
Forty years of liposome research have demonstrated that the anti-tumor efficacy of liposomal therapi...
Poor drug delivery to the posterior segment in patients’ eyes is a major obstacle to the treatment o...
One of the leading causes for blindness in the developed world is Age-related macular degeneration (...
One of the leading causes for blindness in the developed world is Age-related macular degeneration (...
Liposomes can potentially serve as carrier systems for controlled delivery of drugs. The main goal o...
Dry eye disease (DED) is a multifactorial condition resulting in discomfort, visual impairment and e...
In the past thirty years or so, considerable research has been directed towards utilizing lipid bas...
In the past thirty years or so, considerable research has been directed towards utilizing lipid bas...
For treatment of several disorders of the retinal area, the drug molecules need to be directly deliv...
For treatment of several disorders of the retinal area, the drug molecules need to be directly deliv...
MLN-4924 is a newly discovered potent compound that works on the ubiquitin pathway and is currently ...
Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were fi rstdescri...
MLN-4924 is a newly discovered potent compound that works on the ubiquitin pathway and is currently ...
Several efforts have been focused on targeted drug delivery systems for delivering a drug to a parti...
Liposome drug delivery systems are now being developed for a variety of drugs. Scale-up of processes...
Forty years of liposome research have demonstrated that the anti-tumor efficacy of liposomal therapi...